Imagine ending the world’s deadliest pandemic

Tuberculosis (TB) caused 1.25 million deaths in 2023 despite existing treatment options. A safe and effective vaccine would be a powerful tool to drive down TB infections, morbidity, and deaths in high-burden countries and communities. Meet MTBVAC, one of the most promising TB vaccine candidates in development today.